Ocular Ischemic Syndrome
文献摘要
Ocular ischemic syndrome (OIS) is a rare vision-threatening condition due to chronic ocular hypoperfusion. OIS is typically related to significant stenosis or occlusion of the common or internal carotid arteries, most often secondary to atherosclerosis. Because the ophthalmic artery branches from the carotid artery, decreased flow in the carotid artery results in reduced ocular perfusion. The acute manifestations of the disease are transient ischemic attacks and retinal artery occlusion. In contrast, the chronic manifestations are retinopathy and neovascularization, and their sequelae. The first case of OIS was reported in 1963 by Hedges as retinal hemorrhages and venous dilatation in a patient with complete internal carotid artery occlusion. In the same year, Kearns and Hollenhorst used the term venous stasis retinopathy and reported that about 5% of patients with carotid artery occlusion or stenosis had ocular signs and symptoms. To avoid confusion with cases of nonischemic central retinal vein occlusion, also referred to as venous stasis retinopathy, and because the histopathology of eyes with the disease generally did not reveal inflammation, the term ocular ischemic syndrome was coined by Dr Gary C. Brown and Dr Larry Magargal. OIS is an uncommon but potentially vision-threatening disorder resulting from chronic hypoperfusion of the eye secondary to severe carotid artery occlusive disease. First comprehensively described in the ophthalmic literature in the mid-20th century, OIS is the ocular manifestation of advanced systemic atherosclerotic vascular disease and an important clinical indicator of underlying cerebrovascular insufficiency. Although relatively rare compared with other retinal vascular disorders, OIS carries significant ophthalmic and systemic implications because affected individuals often have a markedly increased risk of stroke, myocardial infarction, and cardiovascular mortality. Consequently, recognition of this condition extends beyond preserving vision and often requires an interdisciplinary evaluation by ophthalmologists, neurologists, vascular surgeons, cardiologists, and primary care clinicians. The ocular circulation is uniquely dependent on a complex vascular network that originates primarily from the ophthalmic artery, the first major intracranial branch of the internal carotid artery. The ophthalmic artery gives rise to numerous branches supplying the retina, choroid, optic nerve, extraocular muscles, eyelids, conjunctiva, and orbital structures. The retina receives its inner blood supply through the central retinal artery, whereas the highly metabolically active outer retina derives nourishment from the choroidal circulation, which is supplied by the posterior ciliary arteries. Under normal physiological conditions, autoregulatory mechanisms maintain relatively stable ocular blood flow despite fluctuations in systemic blood pressure. However, when carotid artery stenosis becomes sufficiently severe, compensatory mechanisms fail, resulting in chronic ocular hypoperfusion and subsequent ischemic injury to multiple ocular tissues. The pathophysiology of OIS is fundamentally distinct from that of acute retinal arterial occlusions. Rather than resulting from a sudden interruption of blood flow due to embolic obstruction, OIS develops gradually as progressive narrowing of the carotid artery reduces perfusion pressure within the ophthalmic circulation. In most cases, significant symptoms emerge when carotid artery stenosis exceeds 70% to 90%, although the degree of ocular involvement may vary according to collateral circulation, systemic hemodynamic status, and individual vascular anatomy. The resulting reduction in ocular perfusion pressure leads to chronic ischemia affecting both the anterior and posterior segments. Over time, prolonged hypoxia triggers endothelial dysfunction, impaired vascular autoregulation, increased vascular permeability, and the production of angiogenic mediators, ultimately contributing to the characteristic clinical manifestations of the disease. OIS primarily affects older adults and is most commonly encountered in individuals with widespread atherosclerotic disease. Traditional cardiovascular risk factors, including hypertension, diabetes mellitus, hyperlipidemia, smoking, obesity, and advanced age, are frequently present. Men are generally affected more often than women, reflecting the higher prevalence of severe carotid artery disease in men. Although atherosclerosis accounts for the majority of cases, OIS may also occur in association with other vascular disorders, including giant cell arteritis, Takayasu arteritis, fibromuscular dysplasia, carotid dissection, radiation-induced vasculopathy, and hypercoagulable states. Recognition of these less common etiologies is important, particularly in younger patients who present with ischemic ocular findings without traditional cardiovascular risk factors. The clinical significance of OIS extends beyond visual morbidity because it frequently represents a manifestation of advanced systemic vascular compromise. Results from numerous studies demonstrated that patients diagnosed with OIS exhibit a substantially elevated risk of future cerebrovascular and cardiovascular events. In many individuals, ocular symptoms may precede a transient ischemic attack, ischemic stroke, or myocardial infarction, thereby providing a critical opportunity for early systemic intervention. The ophthalmologist may therefore play a pivotal role in identifying previously undiagnosed carotid artery disease and facilitating timely referral for vascular assessment and risk-factor modification. A distinctive feature of OIS is its ability to affect virtually every ocular tissue supplied by the ophthalmic circulation. Chronic ischemia may involve the retina, choroid, optic nerve, iris, ciliary body, conjunctiva, and extraocular structures. This widespread involvement reflects the diffuse nature of perfusion impairment and distinguishes OIS from many localized retinal vascular disorders. Furthermore, the coexistence of anterior and posterior segment manifestations often creates a complex clinical picture that may resemble diabetic retinopathy, retinal vein occlusion, chronic uveitis, neovascular glaucoma, or other ischemic retinal conditions. Such overlap contributes to underdiagnosis and delayed recognition in routine clinical practice. Advances in ocular imaging have significantly enhanced the understanding of OIS and its underlying hemodynamic alterations. Modern multimodal imaging techniques provide unprecedented insights into retinal and choroidal perfusion abnormalities. Optical coherence tomography angiography (OCTA) has emerged as a valuable noninvasive modality for evaluating microvascular alterations and capillary perfusion deficits associated with chronic ocular ischemia. Enhanced-depth imaging optical coherence tomography has further improved characterization of choroidal structural changes, while ultra-widefield angiography enables comprehensive assessment of peripheral retinal ischemia. These technologies have expanded knowledge of disease mechanisms and may facilitate earlier detection of subclinical vascular compromise. Recent investigations have highlighted the importance of ocular blood-flow assessment in understanding ischemic eye diseases. Color Doppler imaging, laser speckle flowgraphy, and other vascular imaging modalities have demonstrated significant reductions in blood flow in the ophthalmic, central retinal, and posterior ciliary arteries in affected patients. Such findings reinforce the concept that OIS represents a hemodynamic disorder involving both macrovascular and microvascular dysfunction. Contemporary research increasingly focuses on quantitative biomarkers of ocular perfusion and their potential role in disease monitoring and prognostication. From a public health perspective, OIS assumes increasing relevance as populations age and the global burden of atherosclerotic cardiovascular disease continues to rise. Improvements in life expectancy have led to a growing number of individuals living with chronic vascular disease, thereby increasing the population at risk for ocular complications related to systemic hypoperfusion. At the same time, advances in carotid imaging, vascular surgical procedures, endovascular interventions, and medical therapy have created new opportunities for preventing irreversible visual loss and reducing systemic morbidity. Early recognition of OIS remains essential because timely identification of carotid artery disease may significantly influence both ocular and systemic outcomes. Ultimately, ocular ischemic syndrome represents a unique intersection between ophthalmology and vascular medicine. OIS exemplifies how ocular findings can serve as important markers of systemic disease and underscores the eye's role as a window into the body's vascular health. A thorough understanding of its pathophysiology, epidemiology, and clinical significance is crucial for clinicians caring for patients with visual symptoms and cardiovascular risk factors. Prompt recognition of OIS not only aids in preserving vision but may also provide a life-saving opportunity to identify and address advanced carotid artery disease before catastrophic neurological or cardiovascular events occur.